Enzymatic debridement is a selective method used to remove infected and dead tissues from wounds, promoting healing. In this technique, specific enzymes are applied to the wound, breaking down collagen and other proteins present in infectious tissues. The enzymes facilitate the removal of dead tissues, creating a favorable environment for wound healing. The growing adoption of enzymatic debridement in wound care drives the market for these specialized wound management products.
According to Data Bridge Market Research, the Enzymatic Wound Debridement Market accounted for USD 884.45 million in 2022, and is expected to reach USD 1,441.91 million by 2030, at a CAGR of 6.3% during the forecast period 2023 to 2030.
“Rise in cancer cases”
The high global mortality rate and burden of cancer, particularly in middle- and low-income countries, drive the demand for effective healthcare solutions such as enzymatic wound debridement. The significant prevalence of chronic diseases in the United States, accounting for a majority of healthcare expenditures, further emphasizes the need for advanced wound management techniques. These factors create a favorable market environment, fueling the growth of the enzymatic wound debridement market as a vital healthcare solution.
What restraints the growth of the enzymatic wound debridement market?
“High costs associated with chronic wound treatment”
The global enzymatic wound debridement market may face challenges due to the high costs associated with chronic wound treatment. A study published in the Journal of Medical Economics highlights that the direct cost of collagenase debridement, a commonly used enzymatic method, is higher compared to hydrogel debridement. This cost disparity could potentially limit the adoption and growth of enzymatic wound debridement, requiring a careful assessment of cost-effectiveness in wound management strategies.
Segmentation: Enzymatic Wound Debridement Market
The enzymatic wound debridement market is segmented on the basis of type, product, dosage, and end user.
- On the basis of type, the enzymatic wound debridement market is segmented into chronic wound, and acute wound.
- On the basis of product, the enzymatic wound debridement market is segmented into collagenase product, papain product, and others.
- On the basis of dosage, the enzymatic wound debridement market is segmented into ointment, gel, spray emulsion, and dressing.
- On the basis of end user, the enzymatic wound debridement market is segmented into hospitals, homecare, others.
Regional Insights: North America dominates the Enzymatic Wound Debridement Market
North America holds a dominant position in the enzymatic wound debridement market due to the increasing incidence of sports injuries and traffic accidents. The presence of several prominent players in the region further contributes to market expansion during the forecast period.
Prevê-se que a Ásia-Pacífico apresente a maior taxa de crescimento no mercado de desbridamento enzimático de feridas entre 2023 e 2030. O crescimento da região é impulsionado pelo desenvolvimento das nações avançadas e pela expansão do setor do turismo médico. Estes fatores criam oportunidades para a expansão do mercado de desbridamento enzimático de feridas na região.
Para saber mais sobre o estudo, visite https://www.databridgemarketresearch.com/reports/global-enzymatic-wound-debridement-market
Os principais participantes que operam no mercado de desbridamento enzimático de feridas incluem:
- Smith+Nephew (Reino Unido)
- ConvaTec, Lda. (Reino Unido)
- PAUL HARTMANN AG (Alemanha)
- Integra LifeSciences (EUA)
- Medline Industries, Inc. (EUA)
- B.Braun SE (Alemanha)
- RLS Global (Suécia)
- Solsys Medical (EUA)
- Mölnlycke Health Care AB (Suécia)
- DeRoyal Industries (EUA)
- MediWound (Alemanha)
- Healthpoint, Ltd (Reino Unido)
- Zimmer Biomet (EUA)
- Suzhou e Science & Technology Development Corp (China)
- Lohmann & Rauscher GmbH & Co. KG (Alemanha)
- PulseCare Medical (EUA)
- BioMonde (Reino Unido)
- Bioventus LLC (EUA)
Acima estão os principais participantes abordados no relatório. Para saber mais sobre a lista exaustiva de empresas do mercado de desbridamento enzimático de feridas, contacte https://www.databridgemarketresearch.com/contact
Metodologia de Investigação: Mercado Global de Desbridamento Enzimático de Feridas
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com grandes tamanhos de amostra. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados, que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Além disso, os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha do tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise da quota de mercado da empresa, padrões de medição, análise global vs. regional e de participação dos fornecedores. Solicite a chamada de um analista em caso de dúvidas adicionais.
